Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-046870

Options or other derivatives

  • SVP, Diagnostics, clonoSEQ acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ 2020-08-13 Grant or award · Stock Option (Right to Buy) +20,000 20,000 D
Loading xslF345X03/doc4.xml…